Chinese vaccine maker CanSino Biologics' sign on its building in Tianjin on November 20, 2018. Photo Reuters

Coronavirus vaccine developer CanSino offers shares in China’s second-most expensive initial public offering

  • CanSino has priced the A shares of its secondary listing at 209.71 yuan each, the second-most expensive offering price on the mainland’s bourses
  • Hong Kong-traded shares of CanSino more than tripled this year on prospects of the Covid-19 vaccine
Topic |   IPO
Chinese vaccine maker CanSino Biologics' sign on its building in Tianjin on November 20, 2018. Photo Reuters
READ FULL ARTICLE